SHUKRA PHARMACEUTICALS
|
The Current P/S Ratio of SHUKRA PHARMACEUTICALS is 23.47.
| Share Price | ₹30.3 | May 12,2026 |
| Market Cap | ₹1,331.1 Cr | |
| Sales-TTM | ₹56.7 Cr | TTM-Standalone Results |
| Price/Sales | 23.47x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of SHUKRA PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹1,331.1 Cr] as on May 12,2026
(/) Sales [ ₹56.7 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 23.47x ]
Thus, for SHUKRA PHARMACEUTICALS , the investors are currently willing to pay '23.47 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SHUKRA PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of SHUKRA PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of SHUKRA PHARMACEUTICALS
PS Ratio Performance Analysis for SHUKRA PHARMACEUTICALS
- SHUKRA PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 7.11x.
- SHUKRA PHARMACEUTICALS 's operated at median p/e ratio of 0.62x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SHUKRA PHARMACEUTICALS 's p/e ratio peaked in Mar2025 at 29.36x.
- SHUKRA PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2023 of 0.31x.
How does SHUKRA PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| SHUKRA PHARMACEUTICALS | 56.7 | 23.47 | 1,331.1 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 7.80 | 442,893.0 |
| DIVIS LABORATORIES LTD | 10,314.0 | 17.10 | 176,367.0 |
| CIPLA LTD | 28,351.1 | 3.68 | 104,366.0 |
| TORRENT PHARMACEUTICALS LTD | 12,742.0 | 11.63 | 148,241.0 |
| DR REDDYS LABORATORIES LTD | 33,700.2 | 3.15 | 106,010.0 |
| MANKIND PHARMA LTD | 13,914.1 | 7.05 | 98,147.9 |
| ZYDUS LIFESCIENCES LTD | 26,089.3 | 3.59 | 93,655.2 |
| LUPIN LTD | 27,958.0 | 3.67 | 102,691.0 |
| AUROBINDO PHARMA LTD | 33,181.9 | 2.61 | 86,461.0 |
| ABBOTT INDIA LTD | 6,929.1 | 8.25 | 57,156.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SHUKRA PHARMACEUTICALS 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.61x |
| Max industry PS | 23.47x |
| Median industry PS | 7.05x |
| Average industry PS | 8.36x |
You may also like the below Video Courses